This document provides a summary of 6 late-breaking sessions to attend at the Heart Rhythm Society Scientific Sessions in Boston from May 13-16, 2015. The sessions include: (1) a study on the impact of remote monitoring on clinical events and healthcare utilization; (2) a randomized global trial comparing uninterrupted rivaroxaban to vitamin K antagonists in patients undergoing catheter ablation; and (3) a study comparing cryoballoon versus open irrigated radiofrequency ablation in patients with paroxysmal atrial fibrillation. The other sessions include: (4) first-in-human experience with a miniaturized transcatheter pacing system; (5) results from the Canadian Registry of Card

1. Top 6 Late-Breaking
Sessions to Attend
at HRS.15
Heart Rhythm Society Scientific Sessions
Wednesday, May 13 — Saturday, May 16, 2015
Boston, Massachusetts

2. (1) Thursday, May 14 1:30–1:45 pm, Ballroom West
Impact of Remote
Monitoring on Clinical
Events & Healthcare
Utilization: A Nationwide
Assessment
Jonathan P. Piccini, MD
Duke University Medical Center
Durham, N.C.

3. (2) Thursday, May 14 1:45–2:00 pm, Ballroom West
VENTURE-AF: A
Randomized Global Trial
Evaluating Uninterrupted
Rivaroxaban & Vitamin K
Antagonists in Patients
Undergoing Catheter
Ablation for Nonvalvular
Atrial Fibrillation
Andrea Natale, MD
Texas Cardiac Arrhythmia Institute
Austin, Texas

4. (3) Thursday, May 14 2:00–2:15 pm, Ballroom West
Cryoballoon versus Open
Irrigated Radiofrequency
Ablation in Patients with
Paroxysmal Atrial
Fibrillation: The
Prospective, Randomized,
Controlled, Noninferiority
FreezeAF Study
Dr. Armin Luik
Städtisches Klinikum Karlsruhe
Karlsruhe, Germany

5. (4) Friday, May 15 8:00–8:15 am, Ballroom West
Performance of a
Miniaturized
Transcatheter Pacing
System: First in-human
Experience
Philippe Ritter, MD
Hopital Haut-Leveque
Pessac, France

6. (5) Friday, May 15 8:30–8:45 am, Ballroom West
Canadian Registry of
Cardiac Implantable
Electronic Device
Outcomes: Phase 1
Riata Lead on Advisory
(CREDO)
Ratika Parkash, MD
Queen Elizabeth II Health Sciences Centre
at Dalhousie University
Halifax, Nova Scotia

7. (6) Friday, May 15 9:15–9:30 am, Ballroom West
Visually Guided Laser
Balloon (VGLB) Pulmonary
Vein Isolation for the
Treatment of Paroxysmal
Atrial Fibrillation (PAF):
Results of the Prospective
Multicenter Randomized
Heartlight Study
Vivek Y. Reddy, MD, Mount Sinai School
of Medicine, New York, N.Y.